SciNeuro Pharmaceuticals

Developer of new drugs designed to transform the treatment of CNS diseases with a dedication that begins and ends with patients. The company's drugs have a strong CNS product pipeline through internal...

Healthcare

Rockville, MD, United States

Founded 2020

29 employees

Website

Valuation

Share Price

N/A

Total Raised

$153M

Last Round

N/A

Investors

+9 other investors

View all 9 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock SciNeuro Pharmaceuticals's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required